Susquehanna International Group Portfolio holdings
Susquehanna International Group (SIG), founded in 1987 by Jeff Yass and a group of friends, is a privately held global quantitative trading and technology firm headquartered in Bala Cynwyd, Pennsylvania. Specializing in trading equities, fixed income, commodities, derivatives, and ETFs, SIG has grown into a major market maker, handling around 600 equity options and 45 index options across exchanges like the CBOE, while employing over 3,000 people worldwide. The firm leverages a data-driven, probabilistic approach—rooted in the founders’ poker-playing days—to provide liquidity and competitive pricing in financial markets, with additional ventures in private equity, venture capital (notably an early investment in ByteDance, TikTok’s parent company), and sports betting analytics. Known for its innovative culture and use of game theory, SIG operates offices across North America, Europe, Asia, and Australia, maintaining a low-profile yet influential presence in global finance.
Top Buys
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$517M |
| 2 |
Micron Technology
MU
|
+$458M |
| 3 |
Super Micro Computer
SMCI
|
+$417M |
| 4 |
Nike
NKE
|
+$413M |
| 5 |
Broadcom
AVGO
|
+$377M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$6.49B |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$3B |
| 3 |
Amazon
AMZN
|
+$1.56B |
| 4 |
Microsoft
MSFT
|
+$1.14B |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$908M |
Sector Composition
| 1 | Technology | 22.21% |
| 2 | Consumer Discretionary | 9.64% |
| 3 | Financials | 7.05% |
| 4 | Healthcare | 6.25% |
| 5 | Communication Services | 5.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2626
Innovator US Equity Buffer ETF March
BMAR
$228M
| $915K | ﹤0.01% |
21,200
-16,057
| -43% | -$693K |
|
2627
Invesco PHLX Semiconductor ETF
SOXQ
$556M
| $915K | ﹤0.01% |
21,226
+14,611
| +221% | +$630K |
|
2628
SPDR MSCI EAFE Fossil Fuel Reserves Free ETF
EFAX
$398M
| $914K | ﹤0.01% |
22,411
+15,291
| +215% | +$624K |
|
2629
iShares Interest Rate Hedged Long-Term Corporate Bond ETF
IGBH
$107M
| $914K | ﹤0.01% |
+37,645
| New | +$914K |
|
2630
Alamo Group
ALG
$2.4B
| $914K | ﹤0.01% |
5,281
+1,883
| +55% | +$326K |
|
2631
Vicor
VICR
$2.38B
| $913K | ﹤0.01% |
27,526
+7,283
| +36% | +$242K |
|
2632
FT Vest US Equity Enhance & Moderate Buffer ETF March
XMAR
$173M
| $912K | ﹤0.01% |
26,379
+18,207
| +223% | +$629K |
|
2633
Harrow
HROW
$1.64B
| $912K | ﹤0.01% |
43,644
-97,353
| -69% | -$2.03M |
|
2634
Acushnet Holdings
GOLF
$4.37B
| $911K | ﹤0.01% |
14,353
+11,036
| +333% | +$701K |
|
2635
Goldman Sachs MarketBeta International Equity ETF
GSID
$853M
| $910K | ﹤0.01% |
16,258
+10,895
| +203% | +$610K |
|
2636
Innovator US Equity Accelerated ETF Quarterly
XDSQ
$74.5M
| $909K | ﹤0.01% |
27,389
+9,743
| +55% | +$323K |
|
|
OPRA
2637
Opera Ltd
OPRA
$1.68B
| $909K | ﹤0.01% |
+64,744
| New | +$909K |
|
|
CHGX
2638
DELISTED
AXS Change Finance ESG ETF
CHGX
| $906K | ﹤0.01% |
25,068
+5,351
| +27% | +$193K |
|
|
INEQ
2639
Columbia International Equity Income ETF
INEQ
$48.7M
| $906K | ﹤0.01% |
29,828
-6,692
| -18% | -$203K |
|
2640
Pennant Group
PNTG
$834M
| $905K | ﹤0.01% |
39,034
-67,526
| -63% | -$1.57M |
|
2641
SiriusPoint
SPNT
$2.07B
| $905K | ﹤0.01% |
74,164
+57,475
| +344% | +$701K |
|
|
IBTX
2642
DELISTED
Independent Bank Group, Inc.
IBTX
| $903K | ﹤0.01% |
19,842
+6,135
| +45% | +$279K |
|
2643
Kura Oncology
KURA
$716M
| $903K | ﹤0.01% |
43,859
-551,020
| -93% | -$11.3M |
|
2644
Adtalem Global Education
ATGE
$5.06B
| $902K | ﹤0.01% |
13,231
+8,701
| +192% | +$593K |
|
2645
iShares MSCI Ireland ETF
EIRL
$59.8M
| $901K | ﹤0.01% |
13,989
+7,152
| +105% | +$461K |
|
2646
Dyne Therapeutics
DYN
$1.87B
| $901K | ﹤0.01% |
25,521
-415,013
| -94% | -$14.6M |
|
2647
Donaldson
DCI
$9.45B
| $900K | ﹤0.01% |
12,581
-62,390
| -83% | -$4.46M |
|
|
UMH
2648
UMH Properties
UMH
$1.25B
| $899K | ﹤0.01% |
56,202
-23,385
| -29% | -$374K |
|
2649
Matthews China Discovery Active ETF
MCHS
$3.45M
| $898K | ﹤0.01% |
35,137
-30,414
| -46% | -$778K |
|
2650
Xenon Pharmaceuticals
XENE
$2.85B
| $898K | ﹤0.01% |
23,036
-610
| -3% | -$23.8K |
|